Suchergebnisse - "Wan, Yafeng"

PubPharm (30)

1

Minimal-access video-assisted retroperitoneal and/or transperitoneal debridement (VARTD) in the management of infected walled-off pancreatic necrosis with deep extension : initial experience from a prospective single-arm study

enthalten in: European journal of medical research | 2023

von Wei, W. | Tang, Y. | Peng, Z. | +22

2

Minimal-access video-assisted retroperitoneal and/or transperitoneal debridement (VARTD) in the management of infected walled-off pancreatic necrosis with deep extension: initial experience from a prospective single-arm study

enthalten in: European journal of medical research | 2023

von Wei, W. | Tang, Y. | Peng, Z. | +22

3

Minimal-access video-assisted retroperitoneal and/or transperitoneal debridement (VARTD) in the management of infected walled-off pancreatic necrosis with deep extension: initial experience from a prospective single-arm study

enthalten in: European journal of medical research | 2023

von Wei, W. | Tang, Y. | Peng, Z. | +22

4

RNA binding protein-based risk score model for prognosis prediction of patients with hepatocellular carcinoma

enthalten in: Chinese medical journal | 2022

von Xu, S. | Ding, N. | Zheng, S. | +4

5

CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression

enthalten in: International journal of molecular sciences | 2022

von Zhu, H. | Zhou, W. | Wan, Y. | +3

6

Light-activatable multifunctional paclitaxel nanoprodrug for synergistic chemo-photodynamic therapy in liver cancer

enthalten in: BioFactors (Oxford, England) | 2022

von Zhu, H. | Zhou, W. | Wan, Y. | +3

7

Novel γδ T cell-based prognostic signature to estimate risk and aid therapy in hepatocellular carcinoma

enthalten in: BMC cancer | 2022

von Wang, J. | Ling, S. | Ni, J. | +1

8

Novel γδ T cell-based prognostic signature to estimate risk and aid therapy in hepatocellular carcinoma

enthalten in: BMC cancer | 2022

von Wang, J. | Ling, S. | Ni, J. | +1

9

Identification of hub genes and candidate drugs in hepatocellular carcinoma by integrated bioinformatics analysis

enthalten in: Medicine | 2021

von Chen, X. | Xia, Z. | Wan, Y. | +1

10

C-X-C chemokine receptor 2 (Cxcr2) promotes hepatocellular carcinoma immune evasion via regulating programmed death-ligand 1 (PD-L1)

enthalten in: Biological chemistry | 2021

von Wan, Y. | Ge, K. | Zhou, W. | +3